New York Life Investment Management’s Inogen INGN Stock Holding History

New York Life Investment Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27,778	Closed	-$153K	–	1427
2023 Q4	$153K	Sell	27,778 -752	-3%	-$3.97K	﹤0.01%	1303
2023 Q3	$149K	Sell	28,530 -4,494	-14%	-$31.9K	﹤0.01%	1283
2023 Q2	$381K	Sell	33,024 -6,742	-17%	-$79.5K	﹤0.01%	1074
2023 Q1	$496K	Buy	39,766 +22,267	+127%	+$426K	0.01%	697
2022 Q4	$345K	Buy	17,499 +1,972	+13%	+$42.5K	﹤0.01%	1096
2022 Q3	$377K	Buy	15,527 +1,143	+8%	+$31.6K	﹤0.01%	987
2022 Q2	$348K	Buy	+14,384	New	+$382K	﹤0.01%	1092

Other funds holding INGN

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

New York Life Investment Management's INGN Position: Q1 2024 in Review

New York Life Investment Management sold out of Inogen (INGN) in Q1 2024, closing a stake of 27,778 shares — an estimated $153K sold.

New York Life Investment Management first reported a position in INGN in Q2 2022 and held it in 7 quarters. The position peaked at $496K in Q1 2023. 129 funds tracked by Wall St. Rank hold INGN as of Q1 2024.

New York Life Investment Management reported no remaining Inogen position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 27,778 Inogen shares in Q1 2024, an estimated $153K.
New York Life Investment Management first reported a position in Inogen in Q2 2022 and held it in 7 quarters.
New York Life Investment Management's Inogen position peaked at $496K in Q1 2023.
129 funds tracked by Wall St. Rank held Inogen as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.